Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 12, 1999, Pages 2910-2914

  Al Abdely, Hail M ^a,b,c   Graybill, John R ^b,c   Loebenberg, David ^d   Melby, Peter C ^b,c  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; POSACONAZOLE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LEISHMANIA DONOVANI; LIVER; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROMASTIGOTE; SKIN LEISHMANIASIS; SPLEEN; VISCERAL LEISHMANIASIS;

EID: 0032763329     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.12.2910     Document Type: Article

References (15)

1. Al-Abdely, H. M., J. R. Graybill, R. Bocanegra, L. Najvar, E. Montalbo, S. L. Regen, and P. C. Melby. 1998. Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis. Antimicrob. Agents Chemother. 42: 2542-2548.
2. Alvar, J., C. Canavate, B. Gutierrez-Solar, M. Jimenez, F. Laguna, R. Lopez-Velez, R. Molina, and J. Moreno. 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin. Microbiol. Rev. 10:298-319.
3. Berman, J. D. 1997. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24:684-703.
4. Berman, J. D., L. J. Goad, D. H. Beach, and G. G. Holz, Jr. 1986. Effects of ketoconazole on sterol biosynthesis by Leishmania mexicana mexicana amastigotes in murine macrophage tumor cells. Mol. Biochem. Parasitol. 28:85-92.
5. Dan, M., E. Verner, J. el-On, F. Zuckerman, and D. Michaeli. 1986. Failure of oral ketoconazole to cure cutaneous ulcers caused by Leishmania braziliensis. Cutis 38:198-199.
6. Dogr a, J., and V. N. Saxena. 1996. Itraconazole and leishmaniasis: a randomised double-blind trial in cutaneous disease. Int. J. Parasitol. 26:1413-1415.
7. Gasser, R. A., Jr., A. J. Magill, C. N. Oster, E. D. Franke, M. Grogl, and J. D. Berman. 1994. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin. Infect. Dis. 18:83-90.
8. Halim, M. A., O. Alfurayh, M. E. Kalin, S. Dammas, A. al-Eisa, and G. Damanhouri. 1993. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate. Clin. Infect. Dis. 16:397-399.
9. Mishra, M., U. K. Biswas, A. M. Jha, and A. B. Khan. 1994. Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar. Lancet 344:1599-1600.
10. Momeni, A. Z., T. Jalayer, M. Emamjomeh, N. Bashardost, R. L. Ghassemi, M. Meghdadi, A. Javadi, and M. Aminjavaheri. 1996. Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study. Arch. Dermatol. 132:784-786.
11. Oakley, K. L., C. B. Moore, and D. W. Denning. 1997. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp. Antimicrob. Agents Chemother. 41:1124-1126.
12. Rashid, J. R., K. M. Wasunna, G. S. Gachihi, P. M. Nyakundi, J. Mbugua, and G. Kirigi. 1994. The efficacy and safety of ketoconazole in visceral leishmaniasis. East Afr. Med. J. 71:392-395.
13. Rosenthal, E., P. Marty, I. Poizot-Martin, J. Reynes, F. Pratlong, A. Lafeuillade, D. Jaubert, O. Boulat, J. Dereure, and F. Gambarelli. 1995. Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans. R. Soc. Trop. Med. Hyg. 89:159-162.
14. Van Voorhis, W. C. 1990. Therapy and prophylaxis of systemic protozoan infections. Drugs 40:176-202.
15. Walton, B. C. 1987. American cutaneous and mucocutaneous leishmaniasis, p. 644. In W. Peters and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine, vol. II. Academic Press, London, United Kingdom.